Aura Biosciences, Inc. (AURA)

Aura Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	38.23	31.69	41.06	121.58	149.06	17.39
Short-Term Investments	89.77	119.4	185.09	67.23	-	-
Cash & Short-Term Investments	127.99	151.09	226.15	188.81	149.06	17.39
Cash Growth	-36.91%	-33.19%	19.78%	26.66%	757.03%	-46.40%
Prepaid Expenses	1.17	1.7	1.82	2.17	2.73	0.05
Restricted Cash	-	-	0.02	0.02	0.02	0.02
Other Current Assets	5.35	7.83	3.81	5.7	1.88	0.99
Total Current Assets	134.52	160.62	231.79	196.7	153.7	18.46
Property, Plant & Equipment	20.12	20.59	22	26.04	6.2	3.57
Other Long-Term Assets	0.77	1.29	1.28	1.19	0.13	0.08
Total Assets	155.4	182.5	255.08	223.94	160.03	22.1
Accounts Payable	2.01	2.3	1.79	2.92	2.4	0.61
Accrued Expenses	6.57	8.84	6.95	4.25	3.83	1.77
Current Portion of Leases	3.17	3.15	2.69	2.96	0.62	-
Other Current Liabilities	0.41	0.62	0.94	0.33	0.51	0.28
Total Current Liabilities	12.16	14.91	12.36	10.46	7.36	2.66
Long-Term Leases	15.27	15.62	16.87	17.9	0.36	-
Other Long-Term Liabilities	-	-	-	-	-	0.08
Total Liabilities	27.44	30.53	29.23	28.35	7.72	2.74
Additional Paid-In Capital	529.57	525.93	512.62	406.56	304.45	8.17
Retained Earnings	-401.71	-374.23	-287.31	-210.9	-152.14	-116.89
Comprehensive Income & Other	0.11	0.26	0.54	-0.07	-	-
Total Common Equity	127.97	151.97	225.85	195.58	152.32	-108.71
Shareholders' Equity	127.97	151.97	225.85	195.58	152.32	19.36
Total Liabilities & Equity	155.4	182.5	255.08	223.94	160.03	22.1
Total Debt	18.44	18.77	19.56	20.86	0.98	-
Net Cash (Debt)	109.55	132.33	206.59	167.95	148.09	17.39
Net Cash Growth	-40.32%	-35.95%	23.01%	13.41%	751.42%	-46.32%
Net Cash Per Share	2.20	2.67	5.21	5.61	28.70	47.37
Filing Date Shares Outstanding	50.27	50.23	49.5	37.8	29.22	0.44
Total Common Shares Outstanding	50.23	50	49.35	37.77	29.21	0.38
Working Capital	122.35	145.71	219.44	186.25	146.35	15.79
Book Value Per Share	2.55	3.04	4.58	5.18	5.21	-285.22
Tangible Book Value	127.97	151.97	225.85	195.58	152.32	-108.71
Tangible Book Value Per Share	2.55	3.04	4.58	5.18	5.21	-285.22
Machinery	8.67	8.46	7.8	7.43	5.64	4.77
Construction In Progress	0.25	0.27	0.39	1.81	2.37	1.15
Leasehold Improvements	0.47	0.47	-	-	0.01	-

Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q